ArticleBioinformatics (Oxford, England)2025
High-dimensional causal mediation analysis by partial sum statistic and sample splitting strategy in imaging genetics application.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ESPLSM: An Efficient and Interpretable Mediation Analysis Framework Using Sparse Envelopes.Statistics in medicine · 2026Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
summaryCausal mediation analysis investigates the role of mediators in the relationship between exposure and outcome. In the analysis of omics or imaging data, mediators are often high-dimensional, presenting challenges such as multicollinearity and interpretability. Existing methods either compromise interpretability or fail to effectively prioritize mediators. To address these challenges and advance causal mediation analysis in high-dimensional contexts, we propose the Partial Sum Statistic and Sample Splitting Strategy (PS5) framework. Through extensive simulations, we demonstrate that PS5 offers superior type I error control, higher statistical power, reduced bias in mediation effect estimation, and more accurate mediator selection. We apply PS5 to an imaging genetics dataset of chronic obstructive pulmonary disease (COPD) patients from the COPDGene study. The results show successful estimation of the global indirect effect and identification of mediating image regions. Notably, we identify a region in the lower lobe of the lung that exhibits a strong and concordant mediation effect for both genetic and environmental exposures, suggesting potential targets for treatment to mitigate COPD severity caused by genetic and smoking effects. AVAILABILITY AND IMPLEMENTATION: PS5 is publicly available at https://github.com/hung-ching-chang/PS5Med.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.